Health TrialsbyHealthPanel

Effect of Some Drugs on Liver Fibrosis

ConditionLiver Fibroses
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age20+
SponsorSherief Abd-Elsalam

About this trial

Effect of Some Drugs on Liver Fibrosis

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

chronic hepatitis C

Disqualifiers

Acute hepatitis

Thalassemia

Trial design

Design model

Parallel

Treatments tested in this trial

  • Candesartan

    Drug

    Candesartan 8 mg/day

  • Ramipril

    Drug

    ramipril 1.25 mg/day

Treatment groups

45 Participants
are divided into 3 treatment groups
Group A: Control groupNo intervention 0 interventions
Group B: CandesartanActive comparator 1 intervention
Group C: RamiprilActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in Fibroscan or APRI score

Change in Fibroscan or APRI score

Time frame
6 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sherief Abd-Elsalam

Lead sponsor

Tanta University

Sponsor institution

Source ClinicalTrials.gov
Apply now